Diagnostic evaluation of endoscopic ultrasonography with submucosal saline injection for differentiating between T1a and T1b early gastric cancer

Not Applicable

Completed

• Conditions: Neoplasms

• Registration Number: KCT0007919
• Lead Sponsor: Inje University Sanggye Paik Hospital

Brief Summary

Of total 24 patients, 23 were diagnosed with EGC (T1 cancer: 13 as T1a, and 10 as T1b). Standard EUS identified 6 of 13 T1a cancer patients and 3 of 10 T1b cancer patients. Whereas, EUS-SSI identified 12 of 13 T1a cancer patients and 6 of 10 T1b cancer patients. In this study, SSI combined EUS was more accurate than EUS alone in diagnosing T1a and T1b lesions of EGC (75.0 % and 37.5 %, respectively).

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-04-16
• Last Update Posted: 28 November 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Patients who were diagnosed with early gastric cancer from March 2019 to April 2019 and underwent endoscopic ultrasonography for staging, and then underwent gastrectomy or endoscopic procedure (endoscopic submucosal dissection)

Exclusion Criteria

1. If the patients have been diagnosed with early gastric cancer at our hospital, but the treatment result is unknown
2. If the endoscopic findings and endoscopic ultrasonography findings before surgery or procedure are unknown
3. If the patients were diagnosed with advanced gastric cancer after surgery or surgery

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
T stage of gastric cancer before and after treatment

Secondary Outcome Measures

Name	Time	Method
Treatment methods, treatment complications